Lumina Expands its Predictive Analytics and Risk Sensing Capabilities with  Radiance Launch

Lumina Expands its Predictive Analytics and Risk Sensing Capabilities with Radiance Launch

~~AI-powered technology helps organizations anticipate, understand,
manage and mitigate risk~~

Lumina announced today the launch of its new Radiance platform, which uses proprietary, deep-web listening algorithms to uncover risk, provide timely and actionable information and help prevent catastrophic loss. The Radiance platform brings the power of Open-Source Intelligence (OS-INT), Internet Intelligence (NET-INT) and the See Something Say Something app (HUM-INT) for edge-to-edge risk detection.

“The power of Radiance is two-fold – its ability to ingest massive amounts of unstructured, open source data and its real-time ability to analyze that information to predict and prevent organizational risks and threats,” said Allan Martin, CEO of Lumina. “Radiance is designed to help keep people and places safe and secure, and this AI-driven solution will immediately transform how organizations think about risk management and risk mitigation.”

Radiance’s purpose-built, best-in-class algorithms overcome the challenges of massive unstructured data ingestion and prioritization.  Radiance scours the web, prioritizing current behaviors to predict future action. This is an advantage over other technologies, which focus only on historical behavior, which can lead to bias in the results. Additionally, clients can integrate their own structured and unstructured data into Radiance, allowing for correlation of internal databases against open source, publicly available data.

Radiance is a Software-as-a-Service (Saas) platform that includes managed service capabilities. It is rapidly deployable, scalable, highly configurable and user-friendly, and is comprised of the following components:

  • Radiance Open Source Intelligence (OS-INT) is a deep-web listening tool that uses machine learning and artificial intelligence to assess and prioritize risk. Names entered into OS-INT are correlated with content related to 20 different risk factors, known as Behavioral Risk Profiles (BRPs) and cross-referenced with more than 1 million queries into Lumina’s proprietary databases of risk, known as ecosystems. One search across all BRPs equates to more than 465,000 deep web searches.  OS-INT delivers prioritized results in about 5 minutes. A manual search of this magnitude would take a person more than 3 1/2 years to complete.
  • Radiance Internet Intelligence (NET-INT) detects means, motivation and target for attack planning. Its proprietary algorithms continuously identify, monitor, capture and prioritize IP addresses exhibiting anomalous behavior across multiple risk dimensions. The platform collects and stores more than 1 million interactions every day and since its inception has recorded more than 623,000 IP addresses engaged with threat-related risk topics.
  • Radiance Human Intelligence (HUM-INT) is powered by the S4 app, a crowd-sourced, mobile application that allows users to confidentially report concerns in real time. A centralized management portal allows clients to access real-time threats to geo-fenced locations.

“We constantly hear people say, ‘We have so much data, but what can we do with it?’  Radiance solves that problem by ingesting, integrating, correlating and analyzing disparate datasets.  It takes data never designed to identify risk, and prioritizes it – giving our clients an unbiased and fully auditable understanding of human behavior and associated threats,” said Dr. Morten Middelfart, Chief Data Scientist at Lumina.

He added that Radiance’s BRPs solve for the “data noise” obstacle associated with other OS-INT SaaS solutions.  In addition, Radiance drastically outperform existing Natural Language Processing (NLP) approaches to identify names of persons or entities in unstructured data. Radiance performed at a 93.1 percent accuracy level on unstructured, improperly cased documents such as HTML, JSON or computer code and other so-called messy documents compared to 0 percent for Stanford Named Entity Recognizer (NER) and other popular open-source NLP software. Additionally, the BRPs generated with Lumina’s machine learning are “human readable,” making them fully auditable as well.

About Lumina

Lumina is a predictive analytics company founded on the idea that technology is a force for good.  The company’s optimized artificial intelligence capabilities help keep people and places safe and secure through active and early detection of high-risk behavior.  Lumina’s Radiance platform uses proprietary, deep web listening algorithms to uncover risk, provide timely, actionable information, and help prevent catastrophic loss.  Lumina is committed to protecting what matters most, and its Radiance platform is designed to help solve the world’s most challenging problems.

For more information contact Jill Kermes at 202-957-0715 or jill.kermes@luminaanalytics.com

Mission LISA Announces Recommendations to Address Federal Funding Disparities in the Opioid Crisis


Analysis of Major Opioid Grants Shows More Populous States Get More Funding Per Victim, Leaving Smaller, More Impacted States Underfunded

TAMPA, Fla., April 30, 2019 /PRNewswire/ — State allocations of federal opioid grants are biased toward more populous states according to an analysis conducted by Mission LISA (Learning Indicators of Substance Addiction).  Disparities are based on current funding formulas which only address the absolute number of people affected.  To better fund the states most impacted by the crisis – regardless of size – Mission LISA recommends changing funding formulas to account for epidemic severity relative to state population.

“As a guidance to crisis mitigation efforts, Mission LISA recommends federal agencies optimize current opioid funding formulas by incorporating state prevalence as a significant factor,” said Vicky Liao, Director of Mission LISA.  “Smaller states are bearing the brunt of this crisis, and this updated formula would provide them the funds they need for prevention, treatment and intervention.”

She added that as a result of the analysis, Mission LISA developed an optimal formula for determining funding for states which incorporates both absolute numbers of victims as well as state prevalence.

Mission LISA reviewed major opioid grants, including grants from the Substance Abuse and Mental Health Services Administration (SAMHSA), the Health Resources and Services Administration, and the Department of Justice, comparing 2018 state-level funding distribution with the 2017 state ranking by prevalence of opioid misuse.  Results show some highly impacted states were underfunded and received funding that is disproportional to the epidemic prevalence in those states:

Delaware, Maine, New Hampshire, Maryland, and West Virginia.

Incorporating prevalence into the determination of funding for SAMHSA’s State Targeted Response grant would result in an addition of approximately $108 million to at least 37 states and the District of Columbia.  The top five jurisdictions to receive more funding are:

Maine, the District of Columbia, Delaware, New Hampshire, and West Virginia.

About Mission LISA: 
Mission LISA is a data aggregation initiative surrounding America’s national opioid crisis. Using deep web mining and machine learning technology, Lumina Analytics is collecting, synthesizing, and analyzing massive amounts of publicly available data to provide policymakers and healthcare service providers with timely and relevant intelligence surrounding the current state of the crisis and how best to combat nationwide overdose death and addiction. This data drives production of evidence-based policy recommendations and patient-centric treatment pathways, yielding highly targeted solutions for the epidemic.

Mission LISA was launched by Lumina Analytics in 2017 to address the need for more robust and timely data surrounding the opioid crisis in America. Visit www.LuminaAnalytics.com to learn more about Mission LISA technology and data analysis. Follow Mission LISA on LinkedIn and Twitter for relevant intelligence and policy updates.

About the Mission LISA Foundation:  
The Mission LISA Foundation conducts educational meetings, prepares and distributes educational materials, and considers public policy issues in an educational manner, presenting materials and information on a non-biased, non-partisan basis for wholly educational purposes regarding the nation’s opioid epidemic. LISA is an acronym for Learning Indicators of Substance Addiction. Mission LISA Foundation’s Advisory Board is comprised of expert physicians, researchers, academics, policy veterans, and industry professionals.

Lumina Announces Albert Narvades as Chief Financial Officer and expansion into the Washington, DC market

TAMPA, Fla., Feb. 27, 2019 /PRNewswire/ –Lumina, a risk sensing and predictive analytics company, announced today that Albert Narvades has joined the company as chief financial officer.  Narvades’ career spans nearly 25 years in finance and accounting, with broad leadership experience in the software and technology industries. 

“Al has an impressive track record working with Fortune 1000 and Fortune 100 companies as well as with companies that are in a fast-paced, high-growth environment.  This experience, combined with his background in software and technology, make him an excellent addition to the expanding Lumina team,” said Allan Martin, CEO of Lumina. 

Narvades most recently served as chief financial officer at Jagged Peak, where he was head of all finance, business intelligence, legal, insurance and day-to-day human resources of the Software as a Service (SaaS) technology company. Prior to that he served as controller for BP’s alternative energy group/biofuels in Tampa.  There he led accounting, finance and treasury functions. 

“Lumina is a pioneer in the predictive analytics space. Our technologies will help save lives, protect communities and solve some of the biggest problems society faces,” Narvades said. “I’m honored to be a part of the team and join the company at this time of growth and opportunity.” 

Before joining BP, Narvades held a variety of roles with Walter Energy, Inc. (formerly Walter Industries) and its spin-off Walter Investment, including serving as vice president of finance, capital markets focused on structured finance transactions related to securitizations. Narvades began his career with Ernst & Young in 1994 and served in various roles including Audit Manager. He holds both Bachelor of Science and Master degrees in Accounting from the University of Florida, and has been a certified public accountant since 1995.

“In addition to welcoming Al to the team, we are also excited to announce that we have opened our Washington, DCoffice, with a focus on opportunities in the government contracting space,” Martin said. 

“We have opened 2019 with tremendous momentum and are well-positioned to deliver on our strategic growth plan as the year progresses,” he added, noting that earlier this month, Jill Kermes had joined the company as its senior vice president for communications.

Lumina Names Jill Kermes SVP of Communications

Lumina, a predictive analytics and risk sensing company, announced today that Jill Kermes has joined the company as senior vice president of communications.  Kermes has more than 20 years of experience in corporate and brand strategy; corporate social responsibility, issues management, political communications and public affairs consulting.

“Jill is a proven leader with an impressive track record in helping people and organizations translate and simplify strategy into action and we welcome her to the team,” said Allan Martin, CEO of Lumina. “At Lumina, we continue on our mission to solve the world’s most challenging problems.  Jill will play a critical role in helping us communicate that goal as well as the technology that will help us make it a reality.”

In addition to her communications responsibilities, Kermes will also serve in a strategy role for Mission LISA, the company’s data aggregation project focused on providing evidence-based solution for the national opioid crisis. 

“I have always believed in the power of organizations that are driven by purpose and values, and that is certainly the case at Lumina,” Kermes said.  “I am truly inspired by Lumina’s mission and am proud to be part of this committed and passionate team.”

Most recently, Kermes was head of corporate affairs for the Qurate Retail Group, which includes St. Petersburg-based HSN, a position she held following the integration of QVC and HSN in December 2017.  Prior to that she led corporate affairs for HSNi and reported directly to then-President and CEO, Mindy Grossman.

Kermes served as chief corporate affairs officer for SeaWorld Parks & Entertainment, where she was responsible for government affairs, corporate responsibility, external communications, including the company’s historic announcement to end orca breeding. Prior to that, she worked for corporations such as Bridgestone/Firestone and Volkswagen Group of America. Kermes was also a consultant at Ketchum and Public Strategies (now Hill & Knowlton Strategies).

Earlier in her career, she worked closely with Governor Jeb Bush as his communications director during his second administration.  She was the governor’s spokesperson and directed media campaigns to raise awareness for his priorities, including economic development, education, healthcare reform, and disaster preparedness.

Mission LISA Estimates Opioids are Responsible for 89% of the Increase in Drug Deaths in 2017


Organization Provides an Updated Scope of the Opioid Epidemic to Direct Funding and Resource Allocation and State-Level Efforts to Address the Total Patient Population

TAMPA, Fla., Oct. 30, 2018 /PRNewswire/ — Roughly 135 people die every day from an opioid overdose in the U.S. However, more information regarding the current scope of the opioid epidemic – the total number of individuals affected by opioid misuse and the epidemic severity within each state – is needed for an impactful intervention. As a guidance to engage in this crisis and to effectively address the total patient population, Mission LISA implores the President’s Commission on Combating Drug Addiction and the Opioid Crisis, the U.S. Department of Health and Human Services, as well as state and county departments of health, to consider the current magnitude of the epidemic and implement prevention, treatment, and intervention efforts based on state severity.

Mission LISA (Learning Indicators of Substance Addiction) conducted an in-depth quantitative analysis of data-based evidence, gathered by academic and government researchers – including those at the CDC and the SAMHSA – regarding the scope of the opioid epidemic. By analyzing and extrapolating reported data, Mission LISA determined an updated magnitude of the national opioid crisis in 2017.

The organization estimated that in the year 2017:

  • Nearly 89% of the increase in drug overdose deaths was attributed to opioids.
  • Roughly 69% of the total drug overdose deaths were opioid-related.
  • Nearly 1.6 million opioid overdoses occurred nationwide.
  • Approximately 136 people died from an opioid-related overdose every day.
  • Approximately 13.8 million individuals misused opioids.
  • Approximately 2.5 million individuals suffered from opioid addiction.
  • Roughly 2.1 million individuals misused opioids for the first time during the year.

Data show that the number of drug overdose deaths nationwide in 2017 increased 12.5% from 2016. Specifically, opioids are the key driver in the uptick in drug overdose death counts. State-specific estimates show that Pennsylvania, Florida, California, Ohio, and Texas had the largest numbers in opioid overdose deaths and individuals affected by opioid misuse and opioid addiction during the year. On the other hand, the highest prevalence of opioid misuse and opioid addiction and the highest incidence of opioid misuse in 2017 were seen in West Virginia, the District of Columbia, Pennsylvania, Ohio, and Maryland.

Mission LISA’s analysis provides an updated scope of the national opioid crisis based on the increase in drug overdose deaths. State-level findings enable stakeholders to consider state severity when allocating funding and resources to address the epidemic adequately. Currently, the amount of state funding released by the U.S. Department of Health and Human Services correlates to the annual number of opioid overdose deaths per state. However, several areas that suffer from the biggest epidemic burden, namely West Virginia and the District of Columbia, are receiving insufficient funding to address the epidemic. Legislatures can utilize state-specific findings to develop state-level prevention, treatment, and intervention programs, targeting state-specific demands and needs.

Mission LISA will publish additional data-driven analyses and policy recommendations for victims of opioid addiction and overdose. An electronic version of Mission LISA’s quantitative analysis can be accessed here.

Follow Mission LISA on LinkedIn and Twitter for more policy updates.

About Mission LISA:
Mission LISA is a data aggregation initiative surrounding America’s national opioid crisis. Using deep web mining and machine learning technology, Lumina, in partnership with the Mission LISA Foundation, is collecting, synthesizing, and analyzing massive amounts of open-source data to provide policymakers and stakeholders with timely and relevant intelligence surrounding the current state of the crisis and how best to combat nationwide overdose death and addiction. Mission LISA’s Advisory Board is comprised of expert physicians, researchers, academics, policy veterans, and industry professionals, who provide strategic direction for ongoing data systems development and analysis. These data drive production of evidence-based policy recommendations and patient-centric treatment pathways, yielding highly targeted solutions for the epidemic. LISA is an acronym for Learning Indicators of Substance Addiction.

Mission LISA Partners With Advocacy Group to Drive Evidence-based Policy for Drug-Induced Homicide Laws

Together with Health In Justice Action Lab, Mission LISA Addresses Data Ingestion and Aggregation Challenges Regarding Drug-Induced Homicide Laws on the Opioid Epidemic


TAMPA, Fla., Sept. 24, 2018 /PRNewswire/ — Mission LISA has partnered with Health In Justice Action Lab, a not-for-profit advocacy group organization focused on translating data into policy, to assist the organization with its effort to raise awareness about trends and implications of drug induced homicide prosecutions.

Mission LISA has been key in mapping out mechanisms of drug-induced homicide laws across the country to influence research and analysis so Health In Justice can identify and parse out state level legislation across the country.

As more timely and relevant data continues to be a challenge for many organizations hoping to affect policy, Mission LISA was able to assist Health In Justice by deploying machine learning technology to capture large volumes of data related to drug-induced homicide prosecutions on news and media outlets in real-time.

“The data provided by Mission LISA will only continue to support Health In Justice in driving ongoing analysis surrounding the landscape and consequences of drug-induced homicide laws as a means to address the opioid epidemic,” said Kris Smeage, Senior Vice President of Operations for Lumina Analytics.

Currently, 20 states have formal drug-induced homicide laws, while an additional 16 states prosecute “drug delivery resulting in death” under various felony-murder, depraved heart, or involuntary or voluntary manslaughter provisions. These contentious laws are increasingly used by prosecutors and police as a response to the national opioid epidemic. Health In Justice Action Lab is working to affect policy by offering alternatives and educating lawmakers about the implications of this approach.

In addition to using artificial intelligence, Mission LISA engaged an expert team of data analysts to extract specific data points and process drug-induced homicide case data such as: drug-induced homicide charges by statethe total of drug-induced homicide charges per year, and the most active states in pursuing drug-induced homicide charges.

“The analysis provided by Mission LISA has enabled the Health In Justice Action Lab to establish and maintain a public education web portal on an issue of national concern,” said Leo Beletsky, Mission LISA Advisory Board Member and Associate Professor of Law and Health Sciences and Faculty Director, Health in Justice Action Lab.

To access the full case study click here and follow Mission LISA on LinkedIn and Twitter for more policy updates.

About Mission LISA:
Mission LISA is a data aggregation initiative surrounding America’s national opioid crisis. Using deep web mining and machine learning technology, Lumina, in partnership with the Mission LISA Foundation, is collecting, synthesizing, and analyzing massive amounts of open-source data to provide policymakers and stakeholders with timely and relevant intelligence surrounding the current state of the crisis and how best to combat nationwide overdose death and addiction. Mission LISA’s Advisory Board is comprised of expert physicians, researchers, academics, policy veterans, and industry professionals, who provide strategic direction for ongoing data systems development and analysis. These data drive production of evidence-based policy recommendations and patient-centric treatment pathways, yielding highly targeted solutions for the epidemic. LISA is an acronym for Learning Indicators of Substance Addiction.

About the Mission LISA Foundation: 
The Mission LISA Foundation was formed by Lumina as part of its Mission LISA data aggregation project.  Mission LISA was launched by Lumina in 2017 to address the need for more robust and timely data surrounding the opioid crisis in America.  For more information, please contact Kris Smeage at 
Kris.Smeage@LuminaAnalytics.com. Visitwww.LuminaAnalytics.com to learn more about Mission LISA technology and data analysis.